Design, Synthesis, and Biological Evaluation of Novel, Fluorinated Camptothecin Derivatives as Potential Topoisomerase I Inhibitors
Journal of Medicinal Chemistry · 22.10.2026 · 69 (20) · 24030-24052
DOI: 10.1021/acs.jmedchem.6c01583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 25.09.2026. Verfasst von Gui-Sha Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Lanzhou University, Lanzhou730000, People's Republic of China. Hauptthemen laut MEDLINE: Camptothecin, Topoisomerase I Inhibitors, Drug Design, Antineoplastic Agents. Die Arbeit nennt 65 Literaturangaben. Gefördert von: Key Research and Development Program of Gansu Province, Fundamental Research Funds for the Central Universities, Science and Technology Program of Guizhou Province.
Abstract (Originalsprache)
Camptothecin (CPT), a classical topoisomerase I (TOP I) inhibitor, shows potent antitumor activity but is limited by toxicity and lactone instability. Herein, structural optimization of the CPT scaffold was conducted via A-ring fluorination and C-7 and C-17 modifications. A series of fluorinated derivatives were synthesized and evaluated for antiproliferative activity. Structure−activity relationship studies identified C-11 fluorination as optimal, whereas C-7 ethyl and C-17 thiocarbonyl substitutions enhanced potency. Compounds W3 (11F-CPT) and W12 (7Et-11F-CPT) exhibited potential inhibitory effects against pancreatic cancer cells (PANC-1 and BxPC-3) and were selected for further study. Both compounds demonstrated potent antitumor activity in vitro and in vivo with improved stability and safety. Mechanistic studies have indicated that they induce cell cycle arrest and apoptosis and inhibit TOP I activity. These findings clarify the effects of fluorination on CPT activity and support its potential use in pancreatic cancer, thereby providing guidance for scaffold optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Lanzhou University, Lanzhou730000, People's Republic of China.
- School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, People's Republic of China.
ORCID-Profile: Chuan-Rui Xu, Zhi-Jun Zhang, Ying-Qian Liu
Förderung
- Key Research and Development Program of Gansu Province
- Fundamental Research Funds for the Central Universities
- Science and Technology Program of Guizhou Province
- Science and Technology Department of Gansu Province
Zitieren
APA
Chen, G. S., Wang, D. T., Luo, X. F., Li, X., Zhou, L. Y., Mou, G. L., Dai, T. L., Gao, G. P., Pan, Z. Q., Zhang, B. Q., Li, Q. K., Xu, C. R., Zhang, M., Zhang, Z. J., & Liu, Y. Q. (2026). Design, Synthesis, and Biological Evaluation of Novel, Fluorinated Camptothecin Derivatives as Potential Topoisomerase I Inhibitors. Journal of Medicinal Chemistry, 69(20), 24030-24052. https://doi.org/10.1021/acs.jmedchem.6c01583
Vancouver
Chen GS, Wang DT, Luo XF, Li X, Zhou LY, Mou GL, et al. Design, Synthesis, and Biological Evaluation of Novel, Fluorinated Camptothecin Derivatives as Potential Topoisomerase I Inhibitors. Journal of Medicinal Chemistry. 2026;69(20):24030-24052. doi:10.1021/acs.jmedchem.6c01583
BibTeX
@article{Chen2026,
author = {Chen, Gui-Sha and Wang, Deng-Tuo and Luo, Xiong-Fei and Li, Xuan and Zhou, Lin-Yan and Mou, Guo-Liang and Dai, Tian-Li and Gao, Gui-Ping and Pan, Zhong-Qi and Zhang, Bao-Qi and Li, Quan-Ke and Xu, Chuan-Rui and Zhang, Mi and Zhang, Zhi-Jun and Liu, Ying-Qian},
title = {Design, Synthesis, and Biological Evaluation of Novel, Fluorinated Camptothecin Derivatives as Potential Topoisomerase I Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {20},
pages = {24030--24052},
doi = {10.1021/acs.jmedchem.6c01583}
}
EUVIMED